Compare WKEY & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKEY | INCR |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | Switzerland | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 58.6M |
| IPO Year | 2019 | 2021 |
| Metric | WKEY | INCR |
|---|---|---|
| Price | $5.66 | $5.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 26.7K | 5.3K |
| Earning Date | 09-30-2026 | 10-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.54 | $198.80 |
| Revenue Next Year | $52.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.32 | $0.68 |
| 52 Week High | $19.80 | $6.10 |
| Indicator | WKEY | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 64.57 |
| Support Level | $5.74 | $5.12 |
| Resistance Level | $6.94 | $5.68 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 36.23 | 39.11 |
WISeKey International Holding Ltd at the forefront of authentication and cybersecurity technology. It develops, markets, hosts, and supports a range of solutions that enable the secure digital identification and communication of people, content, and objects, by generating digital identities that enable its clients to monetize their existing user bases and, at the same time, expand their own eco-system securely by ensuring only authenticated objects and people can connect. The WISeKey Group operates through five core verticals: SEALSQ, WISeSat, SEALCOIN, WISeID, & WISe.ART. It has two business segments. Semiconductors & ASICs. The majority of its revenue is generated from the Semiconductors segment.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.